Close Menu

ALS

In PNAS this week: modeling of Rift Valley Fever spillover, Asian mosquito could pose malaria threat, and more.

In Science this week: crystal structures of single-stranded RNA bacteriophages found through metagenomic studies, more.

The study also found that certain genes may influence multiple complex traits, while others only affect one phenotype, making them worthwhile therapeutic targets.

The partners will use Medidata's machine learning-based biomarker discovery platform to investigate the amyotrophic lateral sclerosis disease process.

In Nature this week: resources for single-cell analysis, little overlap in the microRNAs used by Salmonella and Shigella to infect host cells, and more.

CNN reports that an experimental treatment is showing promise for treating the genetic form of amyotrophic lateral sclerosis.

The ALS Association is committing $3.5 million, including a $1 million commitment from its Greater New York chapter, while the Tow Foundation is contributing $2.5 million.

New Scientist reports that researchers have tested an ALS gene therapy in a mouse model of disease.

The assay was shown to have a simpler workflow and was able to detect mosaicism, with only a slight decrease in sensitivity compared to a lab-developed test.

Pages

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.